Trial intelligence / Profile preview

Sugammadex Timing for Smooth Extubation in Thyroid Surgery

NCT05751603Not yet recruiting

Sponsor
Ajou University School of Medicine
Start
Oct 2024
Primary completion
Oct 2025
Modality
Biodegradable Polymers, Small Molecules
01

Overview

Randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: extubation quality score. Planned start Oct 2024; status: not yet recruiting.

02

Drugs

Sugammadex
03

Conditions

neuromuscular blockade (NMB)

Beyond the preview

Go deeper on NCT05751603.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05751603.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call